A Double-blind Placebo Controlled Study of Acotiamide Hydrochloride for Efficacy on Gastrointestinal Motility of Patients with Functional Dyspepsia

Trial Profile

A Double-blind Placebo Controlled Study of Acotiamide Hydrochloride for Efficacy on Gastrointestinal Motility of Patients with Functional Dyspepsia

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Acotiamide (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2016 Primary endpoint (Gastric distension (Gastric accommodation (%) by gastric scintigraphy) has been met according to the results presented at the Digestive Disease Week 2016.
    • 24 May 2016 Primary endpoint (Gastric emptying rate (Gastric emptying (T1/2) by gastric scintigraphy) has been met according to the results presented at the Digestive Disease Week 2016.
    • 24 May 2016 Results presented at the Digestive Disease Week 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top